Arbutus Biopharma
ABUS
ABUS
62 hedge funds and large institutions have $44M invested in Arbutus Biopharma in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 25 closing their positions.
Holders
62
Holders Change
-10
Holders Change %
-13.89%
% of All Funds
1.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
16
Reduced
17
Closed
25
Calls
$25K
Puts
$49K
Net Calls
-$24K
Net Calls Change
-$443K
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$3.35M |
| 2 |
2
Jennison Associates
New York
|
$1.31M |
| 3 |
3
Millennium Management
New York
|
$1.08M |
| 4 |
SFM
4
Sphera Funds Management
Tel Aviv,
Israel
|
$1.04M |
| 5 |
5
Hudson Bay Capital Management
Stamford,
Connecticut
|
$1.84M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
William Blair & Company
Chicago,
Illinois
| – | -$45K | -12,700 | Closed |
|
|
SO
77
STRS Ohio
Columbus,
Ohio
| – | -$36K | -10,300 | Closed |
|
|
JG
78
Jefferies Group
New York
| – | -$36K | -10,187 | Closed |
|
|
CG
79
Cutler Group
San Francisco,
California
| – | -$12K | -3,600 | Closed |
|
|
SIAP
80
Sterling Investment Advisors (Pennsylvania)
Berwyn,
Pennsylvania
| – | -$11K | -3,000 | Closed |
|
|
AIP
81
Ameritas Investment Partners
Lincoln,
Nebraska
| – | -$11K | -2,944 | Closed |
|
|
NFG
82
Next Financial Group
Houston,
Texas
| – | -$1K | -200 | Closed |
|